RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
In the next five years, an additional 75,000 seats are expected to be added across both undergraduate and postgraduate levels
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
The company has improved access to quality healthcare for seniors across both urban and rural areas
The facility will be positioned as a Centre of Excellence for tertiary care services
This will be Aster’s fifth hospital in Bengaluru
Subscribe To Our Newsletter & Stay Updated
